Circulating tumor cells in the cerebrospinal fluid: "tapping" into diagnostic and predictive potential

Oncotarget

Volumn 2, Issue 11, 2011, Pages 822-822

  Faltas, Bishoy ^a  

^a ROCHESTER GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR MARKER;

BREAST TUMOR; CENTRAL NERVOUS SYSTEM TUMOR; CEREBROSPINAL FLUID; FEMALE; HUMAN; METASTASIS; NOTE; PATHOLOGY; TUMOR EMBOLISM;

BREAST NEOPLASMS; CENTRAL NERVOUS SYSTEM NEOPLASMS; FEMALE; HUMANS; NEOPLASTIC CELLS, CIRCULATING; TUMOR MARKERS, BIOLOGICAL;

EID: 84858829155     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.349     Document Type: Note

References (5)

1. Chang EL, Lo S: Diagnosis and management of central nervous system metastases from breast cancer. Oncologist 2003; 8:398-410.
2. Weston CL, Glantz MJ, Connor JR: Detection of cancer cells in the cerebrospinal fluid: current methods and future directions. Fluids Barriers CNS 2011; 8:14.
3. Patel AS, Allen JE, Dicker DT, Peters KL, Sheehan JM, Glantz MJ, El-Deiry WS: Identification and enumeration of circulating tumor cells in the cerebrospinal fluid of breast cancer patients with central nervous system metastases. Oncotarget 2011; 2: 752-760.
4. Faltas B, Zeidan A, Peters K, Das A, Joudeh J, Navaraj A, Dolloff NG, Harvey HA, Jiang Y, Allen JE, Dicker DT, El Deiry WS: Identifying circulating tumor stem cells that matter: the key to prognostication and therapeutic targeting. J Clin Oncol 2011; 29:2946-7; author reply 2947-8.
5. Swaby RF, Cristofanilli M: Circulating tumor cells in breast cancer: a tool whose time has come of age. BMC Med 2011; 9:43.